Table 5.
Health Outcomes | Unit of Intake | RR (95% C.I.) | N° of Prospective Studies | References |
---|---|---|---|---|
Total Eggs | ||||
All-cause mortality |
Highest vs. Lowest | 1.06 (1.00–1.12) | 8 | [114] |
Dose-Response | 1.15 (0.99–1.34) | 5 / |
[114] [115] |
|
Total CVDs mortality |
Highest vs. Lowest | No data | ||
Dose-Response | 0.95 (0.88–1.03) | 8 | [164] | |
Total CVDs incidence |
Highest vs. Lowest | No data | ||
Dose-Response | 0.94 (0.89–0.99) | 9 | [164] | |
CHD | Highest vs. Lowest | / / |
6 11 |
[131] [118] |
Dose-Response | / / / / |
6 9 / 12 |
[165] [118] [115] [164] |
|
Stroke | Highest vs. Lowest | / | 10 | [118] |
Dose-Response | / | 10 / |
[118] [115] |
|
0.97 (0.93–1.02) | 6 | [164] | ||
0.91 (0.81–1.02) | 6 | [165] | ||
HBP | Highest vs. Lowest | 0.54 (0.32–0.91) | 1 | [120] |
Dose-Response | 0.25 (0.08–0.74) | 1 | ||
CHF | Highest vs. Lowest | 1.25 (1.12–1.39) | 4 | [118] |
Dose-Response | 1.16 (1.03–1.31) | 4 | ||
1.11 (0.99–1.25) | 4 | [164] | ||
T2D | Highest vs. Lowest | / | 5 | [121] |
Dose-Response | / / |
/ 13 |
[115] [122] |
|
1.16 (1.09–1.23) | 13 | [166] | ||
Overweight/Obesity | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
MetS | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Total cancer mortality |
Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Total cancer incidence |
Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
CRC | Highest vs. Lowest | 1.35 (1.11–1.36) | 4 | [124] |
Dose-Response | / / |
3 / |
[124] [115] |
|
Breast cancer | Highest vs. Lowest | / | 9 | [127] |
Dose-Response | / | 8 | ||
Gastric cancer | Highest vs. Lowest | / | 9 | [128] |
Dose-Response | No data |